Folkhälsan Institute of Genetics, Folkhälsan Research Centre, Helsinki, Finland.
Abdominal Centre Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Diabetes Obes Metab. 2018 Dec;20(12):2759-2767. doi: 10.1111/dom.13456. Epub 2018 Aug 7.
To determine the effect of different stages of diabetic nephropathy (DN) and sex on the excess and absolute morbidity of coronary artery disease (CAD) and stroke in people with type 1 diabetes (T1D) in order to distinguish different cardiovascular disease (CVD) risk profiles in people with T1D.
The study included 4410 people with T1D from the Finnish Diabetic Nephropathy Study (FinnDiane), divided by DN status, and a control population of 12 434 people without diabetes. CVD events were identified from the Finnish nationwide health registries. Cumulative incidences for CAD and stroke were calculated and standardized incidence ratios (SIRs) were estimated between participants with T1D and the control group, stratified by DN status and sex.
There were 487 incident CADs and 290 strokes at the end of 2014 (median follow-up 12.9 years). The cumulative incidence rates of CAD and stroke were similar in men and women within different nephropathy groups. The SIR for CAD was 7.5 (95% confidence interval [CI] 6.9-8.2), 17.2 (95% CI 14.9-19.5) in women and 5.3 (95% CI 4.7-5.9) in men. The women-to-men ratio of SIR increased by nephropathy group: 3.3, 3.7, 5.3 and 6.8 in the normo-, micro- and macroalbuminuria and end-stage renal disease (ESRD) groups, respectively. The SIR for stroke was 5.0 (95% CI 4.3-5.5), similar in men and women. The women-to-men ratio of SIR for stroke was 0.8, 1.3, 1.6 and 1.7, in the normo-, micro- and macroalbuminuria and ESRD groups, respectively. The SIR in participants with normoalbuminuria and an estimated glomerular filtration rate ≥90 mL/min/1.73 m was 3.5 (95% CI 2.5-4.5) for CAD and 1.6 (95% CI 1.0-2.3) for stroke.
Although the excess CVD risk is several-fold greater in women compared to men, the absolute CVD risk in men and women was equal when nephropathy was taken into account. Even participants with normoalbuminuria and normal kidney function were found to have an excess CVD risk compared with the control group without diabetes.
确定不同阶段的糖尿病肾病(DN)和性别对 1 型糖尿病(T1D)患者冠状动脉疾病(CAD)和中风的超额和绝对发病率的影响,以便区分 T1D 患者的不同心血管疾病(CVD)风险特征。
本研究纳入了来自芬兰糖尿病肾病研究(FinnDiane)的 4410 名 T1D 患者,按 DN 状况分组,并以 12434 名无糖尿病的对照组人群作为对照。通过芬兰全国健康登记处确定 CVD 事件。计算 CAD 和中风的累积发病率,并根据 DN 状况和性别对 T1D 患者与对照组进行标准化发病率比(SIR)估计。
截至 2014 年底,共发生 487 例 CAD 和 290 例中风(中位随访 12.9 年)。在不同肾病组中,男性和女性的 CAD 和中风累积发病率相似。CAD 的 SIR 为 7.5(95%置信区间[CI] 6.9-8.2),女性为 17.2(95%CI 14.9-19.5),男性为 5.3(95%CI 4.7-5.9)。SIR 的女性与男性比值随着肾病组的增加而增加:在正常白蛋白尿、微量白蛋白尿和大量白蛋白尿以及终末期肾病(ESRD)组中,分别为 3.3、3.7、5.3 和 6.8。中风的 SIR 为 5.0(95%CI 4.3-5.5),男女相似。中风 SIR 的女性与男性比值在正常白蛋白尿、估算肾小球滤过率≥90ml/min/1.73m2 组中分别为 0.8、1.3、1.6 和 1.7。
尽管与男性相比,女性的 CVD 风险增加了数倍,但考虑到肾病时,男女的绝对 CVD 风险是相等的。即使是正常白蛋白尿和正常肾功能的患者与无糖尿病的对照组相比,也存在 CVD 风险增加的情况。